<code id='FFC0CE314B'></code><style id='FFC0CE314B'></style>
    • <acronym id='FFC0CE314B'></acronym>
      <center id='FFC0CE314B'><center id='FFC0CE314B'><tfoot id='FFC0CE314B'></tfoot></center><abbr id='FFC0CE314B'><dir id='FFC0CE314B'><tfoot id='FFC0CE314B'></tfoot><noframes id='FFC0CE314B'>

    • <optgroup id='FFC0CE314B'><strike id='FFC0CE314B'><sup id='FFC0CE314B'></sup></strike><code id='FFC0CE314B'></code></optgroup>
        1. <b id='FFC0CE314B'><label id='FFC0CE314B'><select id='FFC0CE314B'><dt id='FFC0CE314B'><span id='FFC0CE314B'></span></dt></select></label></b><u id='FFC0CE314B'></u>
          <i id='FFC0CE314B'><strike id='FFC0CE314B'><tt id='FFC0CE314B'><pre id='FFC0CE314B'></pre></tt></strike></i>

          knowledge

          explore

          Duchenne breakthrough therapy leaves behind pioneering families
          Duchenne breakthrough therapy leaves behind pioneering families

          DuchennemusculardystrophyDr.EdwinP.Ewing,Jr./CDCPatFurlongwassittinginherhomeofficeinMiddletown,Ohio

          read more
          Senators: Long
          Senators: Long

          Sen.EdMarkeyofMassachusetts(above)andSen.JoeManchinofWestVirginiahadwordsofwarningforFDACommissioner

          read more
          Alkermes shareholders re
          Alkermes shareholders re

          MarkLennihan/APAlkermesshareholdersvotedThursdaytore-electallofthedrugmaker’scurrentdirectors,ending

          read more

          Biotech stock slump in 2023: awaiting the turnaround

          AdobeThiswassupposedtobetheyearofthebiotechcomeback,whenpromisingnewmedicinesandhigh-dollarbuyoutswo